FDA Approves , Generic ADHD Drugs.<br />The FDA has approved generic versions of Vyvanse for the first time, 'The Hill' reports. .<br />The new medications can treat ADHD <br />in people ages six and up.<br />They can also be used for "binge-eating <br />disorder in adults," 'The Hill' reports. .<br />Approval of the generic medications comes as the U.S. continues to experience a shortage of Adderall, which is commonly used to treat ADHD. .<br />The shortage was first announced <br />by the FDA in October 2022.<br />According to the CDC, ADHD prescriptions surged amid the pandemic as more <br />people turned to telehealth care. .<br />According to the CDC, ADHD prescriptions surged amid the pandemic as more <br />people turned to telehealth care. .<br />The unexpected demand, manufacturing issues <br />and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .<br />The unexpected demand, manufacturing issues <br />and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .<br />The unexpected demand, manufacturing issues <br />and limited supplies of drug ingredients have contributed to the shortage, 'The Hill' reports. .<br />Since ADHD drugs are classified as <br />controlled substances, the FDA and DEA limit how much of the medicine can be produced each year.<br />But the increased demand and limited supply have prompted calls for the threshold to be raised.<br />Earlier this month, the FDA and DEA said <br />they are "working closely with numerous manufacturers, agencies and others in the supply chain to understand, prevent and reduce the impact of these shortages."
